Uncategorized

Boston Scientific has released a video in response to claims that next-generation stents made by Boston Scientific, Abbott and Medtronic can deform, according to a MassDevice report.

Genzyme, a company producing therapies for rare diseases, received FDA clearance for its manufacturing plant in Framingham, Mass., for the production of Fabrazyme, an enxyme replacement therapy for Fabry disease, according to a news release.

In response to reports of increased abuse of prescription painkillers, Delaware's Medicaid program is placing more restrictions on the drugs, according to a Delaware Online report.

Preferred Pain Center in Phoenix has started offering spinal decompression for the treatment of back pain and is offering new customers three free spinal decompression therapy sessions, according to a news release.

Five pain management physicians talk about the most important pain management research in 2011 and its impact on the specialty.

The National Council for Prescription Drug Programs, a not-for-profit pharmacy standards development organization, has published a list of its 2011 accomplishments.

The Pediatric Infectious Diseases Society and the Infectious Diseases Society of America have released guidelines for managing community-acquired pneumonia in children, according to an Agency for Healthcare Research and Quality publication.

The Tennessee Surgical Quality Collaborative led to improvements in procedures including superficial site infection (18.9 percent reduction) and wound disruption (34.3 percent), according to research published in the Journal of the American College of Surgeons.

The FDA granted 510(k) clearance to Medtronic's Aquamantys SBS 5.0 Sheathed Bipolar Sealer for spine surgery, according to a news release.

Thomas Schuler, MD, spine surgeon and president and CEO of Virginia Spine Institute, discusses the outlook for outpatient spine surgery in the next few years.